Overview
Insperity Q2 revenue rises 3% yr/yr but missed analyst expectations
Adjusted EPS for Q2 misses consensus, reflecting higher benefits costs
Co reports Q2 net loss of $5 mln, adjusted EBITDA misses estimates
Outlook
Insperity sees Q3 adjusted EPS between $0.06 and $0.49
Company expects full-year adjusted EPS of $1.81 to $2.51
Insperity forecasts Q3 adjusted EBITDA of $24 mln to $44 mln
Company projects full-year adjusted EBITDA of $170 mln to $205 mln
Result Drivers
HIGHER HEALTHCARE COSTS - Gross profit decline attributed to elevated healthcare costs, including pharmacy trends and large claim activity
REVENUE GROWTH - 3% revenue increase driven by higher pricing and slight increase in average paid WSEEs
BENEFIT PLAN CHANGES - Co implementing benefit plan design changes to address elevated benefits cost trend, per CFO James D. Allison
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$1.66 bln
$1.66 bln (5 Analysts)
Q2 Adjusted EPS
Miss
$0.26
$0.43 (5 Analysts)
Q2 Net Income
-$5 mln
Q2 Adjusted EBITDA
Miss
$32 mln
$39.80 mln (5 Analysts)
Q2 Operating income
Miss
-$7 mln
$16.20 mln (3 Analysts)
Q2 Gross Profit
$223 mln
Press Release: ID:nBwc1B2Tta
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)